Stephen L. Hauser, MD will receive the 2017 Taubman Prize for Excellence in Translational Medical Research for his paradigm-changing discoveries that have paved the way for a highly effective drug for the treatment of multiple sclerosis (MS).
S. Andrew Josephson, M.D. has been appointed by Dean Talmadge E. King, Jr., MD, as the new chair of UC San Francisco's Department of Neurology, effective July 1. Dr. Josephson is the Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor of Neurology. He is the director and founder of UCSF’s Neurohospitalist Program, and has served as the Medical Director of Inpatient Neurology for over a decade. Dr. Stephen Hauser, who has chaired the department for the past 25 years, will remain with the department as Professor and Director of the new UCSF Weill Institute for Neurosciences.
Dr. Robert Edwards, a professor of neurology and the John and Helen Cahill Family Endowed Chair in Parkinson's Disease Research, has been elected to the National Academy of Sciences, one of the highest honors accorded to American scientists. He is the fourth member of the Neurology faculty to be elected to the NAS.
After a 40 year odyssey, the first drug to treat aggressive multiple sclerosis has won FDA approval. It grew out of the work of Dr. Stephen Hauser, chair of neurology at UCSF, whose team persevered for decades and defended their findings that contradicted long-standing assumptions. Ocrelizumab is the first MS drug that targets B cells in the human body.
Dr. Bruce Miller, Professor of Neurology and Director of the UCSF Memory and Aging Center, has been awarded the 2017 Holly Smith Award for Exceptional Service to the School of Medicine. He was also recently elected to the National Academy of Medicine (formerly the Institute of Medicine).
The largest single gift ever to UCSF, a $185 million donation from Sanford I. “Sandy” Weill and Joan Weill, has launched the UCSF Weill Institute for Neurosciences. This new institute will provide resources to our neuroscience researchers and physicians to advance our knowledge and treatment options for diseases affecting the brain and nervous system, including psychiatric disorders.